Columbia Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.75M Buy
8,431
+85
+1% +$86.2K 1.48% 15
2025
Q4
$8.97M Buy
8,346
+352
+4% +$337K 1.59% 15
2025
Q3
$6.1M Buy
7,994
+327
+4% +$243K 1.14% 23
2025
Q2
$5.98M Sell
7,667
-62
-0.8% -$48.2K 1.17% 24
2025
Q1
$6.38M Sell
7,729
-343
-4% -$285K 1.25% 18
2024
Q4
$6.23M Sell
8,072
-1,417
-15% -$1.17M 1.14% 20
2024
Q3
$8.41M Sell
9,489
-49
-0.5% -$44.1K 1.47% 14
2024
Q2
$8.64M Buy
9,538
+473
+5% +$378K 1.61% 11
2024
Q1
$5.28M Buy
9,065
+15
+0.2% +$10.7K 1.07% 27
2023
Q4
$5.28M Buy
9,050
+247
+3% +$144K 1.07% 27
2023
Q3
$4.73M Buy
8,803
+1,025
+13% +$528K 1.04% 29
2023
Q2
$3.65M Buy
7,778
+3,389
+77% +$1.42M 0.78% 38
2023
Q1
$1.51M Hold
4,389
0.34% 63
2022
Q4
$1.61M Hold
4,389
0.39% 60
2022
Q3
$1.42M Buy
4,389
+100
+2% +$31.7K 0.37% 62
2022
Q2
$1.39M Buy
+4,289
New +$1.29M 0.35% 63
2021
Q4
$1.19M Hold
4,289
0.24% 71
2021
Q3
$991K Hold
4,289
0.22% 78
2021
Q2
$984K Sell
4,289
-421
-9% -$84.6K 0.22% 80
2021
Q1
$880K Hold
4,710
0.16% 96
2020
Q4
$795K Hold
4,710
0.16% 97
2020
Q3
$697K Sell
4,710
-75
-2% -$11.6K 0.16% 95
2020
Q2
$786K Buy
4,785
+20
+0.4% +$3.07K 0.19% 84
2020
Q1
$661K Hold
4,765
0.16% 88
2019
Q4
$6.26K Hold
4,765
0.15% 106
2019
Q3
$533K Sell
4,765
-25
-0.5% -$2.78K 0.14% 114
2019
Q2
$531K Hold
4,790
0.14% 111
2019
Q1
$622K Hold
4,790
0.17% 104
2018
Q4
$554K Sell
4,790
-48
-1% -$5.36K 0.17% 100
2018
Q3
$519K Buy
4,838
+48
+1% +$4.8K 0.14% 115
2018
Q2
$409K Hold
4,790
0.12% 123
2018
Q1
$371K Sell
4,790
-280
-6% -$22.5K 0.11% 138
2017
Q4
$428K Hold
5,070
0.12% 131
2017
Q3
$434K Hold
5,070
0.13% 128
2017
Q2
$417K Hold
5,070
0.13% 129
2017
Q1
$426K Hold
5,070
0.14% 124
2016
Q4
$373K Sell
5,070
-590
-10% -$43.9K 0.13% 133
2016
Q3
$454K Sell
5,660
-1,106
-16% -$88.5K 0.16% 120
2016
Q2
$533K Sell
6,766
-570
-8% -$42.9K 0.19% 107
2016
Q1
$528K Sell
7,336
-735
-9% -$55.6K 0.19% 106
2015
Q4
$680K Sell
8,071
-230
-3% -$19.1K 0.27% 91
2015
Q3
$695K Buy
8,301
+25
+0.3% +$2.11K 0.28% 93
2015
Q2
$690K Buy
8,276
+100
+1% +$7.62K 0.26% 99
2015
Q1
$594K Sell
8,176
-440
-5% -$31.3K 0.22% 112
2014
Q4
$594K Sell
8,616
-150
-2% -$10.1K 0.23% 108
2014
Q3
$568K Hold
8,766
0.23% 104
2014
Q2
$545K Hold
8,766
0.22% 106
2014
Q1
$516K Hold
8,766
0.22% 103
2013
Q4
$447K Buy
+8,766
New +$439K 0.2% 109

Other funds holding LLY

Columbia Asset Management's LLY Position: Q1 2026 in Review

Columbia Asset Management increased its Eli Lilly (LLY) stake by 1% in Q1 2026, buying an estimated $86.2K and bringing the position to 8,431 shares worth $7.75M. The position accounts for 1.48% of the portfolio, ranked #15.

Columbia Asset Management first reported a position in LLY in Q4 2013 and has held it in 49 quarters since. The position peaked at $8.97M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Columbia Asset Management held 8,431 shares of Eli Lilly worth $7.75M as of Q1 2026.
  • Columbia Asset Management bought 85 Eli Lilly shares in Q1 2026, an estimated $86.2K.
  • Eli Lilly made up 1.48% of Columbia Asset Management's portfolio in Q1 2026, its #15 holding.
  • Columbia Asset Management first reported a position in Eli Lilly in Q4 2013 and has held it in 49 quarters since.
  • Columbia Asset Management's Eli Lilly position peaked at $8.97M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Columbia Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.